Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Marimed (MRMD) Minority Interest (2016 - 2025)

Marimed (MRMD) has disclosed Minority Interest for 13 consecutive years, with -$1.9 million as the latest value for Q4 2025.

  • Quarterly Minority Interest fell 6.22% to -$1.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$1.9 million through Dec 2025, down 6.22% year-over-year, with the annual reading at -$1.9 million for FY2025, 6.22% down from the prior year.
  • Minority Interest for Q4 2025 was -$1.9 million at Marimed, down from -$1.8 million in the prior quarter.
  • The five-year high for Minority Interest was -$569574.0 in Q1 2021, with the low at -$1.9 million in Q4 2025.
  • Average Minority Interest over 5 years is -$1.5 million, with a median of -$1.6 million recorded in 2022.
  • Peak annual rise in Minority Interest hit 5.39% in 2022, while the deepest fall reached 182.84% in 2022.
  • Over 5 years, Minority Interest stood at -$1.6 million in 2021, then grew by 3.33% to -$1.5 million in 2022, then dropped by 9.2% to -$1.6 million in 2023, then decreased by 6.18% to -$1.8 million in 2024, then fell by 6.22% to -$1.9 million in 2025.
  • According to Business Quant data, Minority Interest over the past three periods came in at -$1.9 million, -$1.8 million, and -$1.8 million for Q4 2025, Q3 2025, and Q2 2025 respectively.